Freda Lewis-Hall, MD, Gives Keynote Address at World Orphan Drug Congress USA

| July 18, 2013

article image
On April 10, 2013, Freda Lewis-Hall, MD, Chief Medical Officer of Pfizer, Inc delivered the keynote speech at Terrappin's World Orphan Drug Congress USA 2013 in Washington, D.C.

Spotlight

Emmi

Emmi® solutions, from Wolters Kluwer Health, helps healthcare organizations extend the reach of care teams in and beyond the care setting, enabling them to build stronger relationships, enhance the care experience, improve health outcomes and support value-based care initiatives, while increasing revenue and reducing costs. Emmi combines a science-based approach to communications design with healthcare expertise and a patented technology platform that brings dynamic, interactive and personalized communications to life.

OTHER ARTICLES

What are the advantages of PCD Pharma Company?

Article | February 17, 2020

PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the business to make a sound decision. Needless to mention that PCD company has a lot to contribute in the medical filed. Worldwide in a medical field, A PCD Pharma Company is playing an essential and crucial role in the rapid growth. The pharma industry is progressing t a fast pace. The company uses the latest technologies for each brand which ensures the safety of products and accepts the responsibility of human health & life by providing better outcomes. To have a drug license number and company registration, the cost to establish the company is quite cost-effective that is15000-20000rs. So this gives people a brilliant opportunity to have their unit without digging a big hole in their bank balance. Indian produces exquisite quality products, which make pharma companies a considerable success.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | February 17, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Top Specialty Pharmacy Therapy Areas

Article | February 17, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | February 17, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Spotlight

Emmi

Emmi® solutions, from Wolters Kluwer Health, helps healthcare organizations extend the reach of care teams in and beyond the care setting, enabling them to build stronger relationships, enhance the care experience, improve health outcomes and support value-based care initiatives, while increasing revenue and reducing costs. Emmi combines a science-based approach to communications design with healthcare expertise and a patented technology platform that brings dynamic, interactive and personalized communications to life.

Events